Holen Sie sich die Stockscreener-App
26.31
1.09%
-0.29
Schlusskurs vom Vortag:
$26.60
Offen:
$26.57
24-Stunden-Volumen:
1.18M
Relative Volume:
0.80
Marktkapitalisierung:
$2.06B
Einnahmen:
$1.29B
Nettoeinkommen (Verlust:
$67.69M
KGV:
34.16
EPS:
0.7701
Netto-Cashflow:
$184.42M
1W Leistung:
+1.62%
1M Leistung:
+13.16%
6M Leistung:
+1.23%
1J Leistung:
+22.20%
1-Tages-Spanne:
$26.15
$26.84
1-Wochen-Bereich:
$25.18
$27.36
52-Wochen-Spanne:
$16.10
$28.75
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
26.31 | 2.11B | 1.29B | 67.69M | 184.42M | 0.7701 |
UNH
Unitedhealth Group Inc
|
399.53 | 373.28B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
99.16 | 128.46B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
391.27 | 87.28B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
285.09 | 77.73B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
362.00 | 45.65B | 137.20B | 1.15B | 1.27B | 9.3439 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
A Look at Progyny Inc (PGNY) After 3.8% Gain -- GF Value $28.04 vs Price $26.63 - GuruFocus
PGNY Stock Price, Quote & Chart - ChartMill
What Progyny (PGNY)'s Governance Shift And $200 Million Buyback Mean For Shareholders - Yahoo Finance
What Progyny (PGNY)'s Supermajority Rollback and US$200 Million Buyback Mean For Shareholders - simplywall.st
Progyny Inc stock (US74340E1038): fertility benefits specialist after recent share price swings - AD HOC NEWS
Progyny (PGNY) Schedule 13G/A Amendment No.4 — Kleiner Perkins shows 0% ownership - Stock Titan
Progyny CFO Mark Livingston sells $64,183 in company stock By Investing.com - Investing.com South Africa
Progyny EVP Allison Swartz sells $45,021 in company stock By Investing.com - Investing.com South Africa
Progyny (NASDAQ:PGNY) EVP Sells $15,022.92 in Stock - MarketBeat
Allison Swartz Sells 1,199 Shares of Progyny (NASDAQ:PGNY) Stock - MarketBeat
Progyny (NASDAQ:PGNY) CFO Sells $64,183.50 in Stock - MarketBeat
Progyny EVP Allison Swartz sells $45,021 in company stock - Investing.com India
Progyny CFO Mark Livingston sells $64,183 in company stock - Investing.com
Progyny (PGNY) CFO Livingston sells shares in 10b5-1 plan, retains 74,688 - Stock Titan
Progyny (PGNY) EVP Swartz logs small share sales under 10b5-1 plan - Stock Titan
Progyny (PGNY) CEO reports 5,361-share tax withholding, holds 811,472 shares - Stock Titan
PGNY (NASDAQ: PGNY) affiliate files Rule 144 reporting sales and vesting - Stock Titan
Progyny Inc stock (US74340E1038): Canaccord upgrade and insider filings put focus on Nasdaq fertilit - AD HOC NEWS
Progyny (PGNY) Authorizes $200M Share Repurchase Program - Yahoo Finance
Progyny Rises Again as Wall Street Keeps Buying Fertility-Benefits Rebound - Bez Kabli
Allison Swartz (PGNY) reports sales of 599, 2,398 and 1,199 shares - Stock Titan
Conservative Guidance Weighed on Progyny (PGNY) Amid Strong Demand and Solid Execution - Insider Monkey
Progyny (PGNY) CFO logs small share sale and tax withholding moves - Stock Titan
Director at Progyny (NASDAQ: PGNY) exercises options and sells stock - Stock Titan
Progyny (NASDAQ: PGNY) executive exercises options with small share sale - Stock Titan
Allison Swartz (PGNY) files Form 144 to sell 1,199 vested shares (06/03/2026) - Stock Titan
PGNY Maintained by B of A Securities -- Price Target Raised to $31 - GuruFocus
[144] Progyny, Inc. SEC Filing - Stock Titan
Mark Livingston plans sale of 279 PGNY shares (NASDAQ: PGNY) - Stock Titan
Progyny, Inc. Stock 12‑Month Price Target Raised to $29.73, Implies 13% Upside - TradingView
BofA Securities Maintains Progyny(PGNY.US) With Buy Rating, Announces Target Price $31 - Moomoo
Jefferies cuts Progyny stock price target on guidance miss - Investing.com
Progyny (PGNY) EVP, GC Swartz sells shares under Rule 10b5-1 plan - Stock Titan
Director proposes sale of 2,676 shares — PGNY (NASDAQ: PGNY) - Stock Titan
A Progyny (PGNY) Insider Sold 5,500 Shares for $137,000 - Yahoo Finance
(PGNY) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Progyny (PGNY) director Kevin Gordon sells 5,500 shares and shifts holdings to trust - Stock Titan
Progyny Inc. (PGNY) Edges Higher Amid Consolidation Near Key LevelsSuperTrend Flip - newsline.com
symbol__ Stock Quote Price and Forecast - CNN
PGNY (NASDAQ: PGNY) affiliate plans sale of 2,398 shares from vested stock - Stock Titan
New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System - marketscreener.com
Fertility patients say tech alone isn’t enough—they want human support - Stock Titan
Progynyn (NASDAQ:PGNY): A Bull Flag Breakout with Strong Fundamentals - ChartMill
Progyny sets $200M share repurchase program - MSN
Progyny (PGNY) investors back charter and bylaw changes easing supermajority votes - Stock Titan
Fertility benefits growth and share buybacks keep Progyny (PGNY) earnings in focus - MSN
Progyny Announces $200 Million Share Repurchase Authorization - The Globe and Mail
Bull of the day: Progyny (PGNY) - MSN
Progyny (PGNY) director receives RSUs, stock options in lieu of cash - Stock Titan
Progyny (PGNY) grants RSUs and stock options to director Dean Lloyd H - Stock Titan
Progyny (PGNY) director Kevin Gordon awarded RSUs and options in new equity grants - Stock Titan
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Progyny Inc-Aktie (PGNY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Swartz Allison | EVP, GC |
Jun 03 '26 |
Sale |
25.02 |
1,199 |
29,999 |
83,316 |
| Swartz Allison | EVP, GC |
Jun 04 '26 |
Sale |
25.08 |
599 |
15,023 |
82,378 |
2.83%
3.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):